NYSE:ARA - American Renal Associates Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $15.32 -0.09 (-0.58 %) (As of 07/16/2018 04:00 PM ET)Previous Close$15.41Today's Range$15.08 - $15.4152-Week Range$9.91 - $24.07Volume114,811 shsAverage Volume162,757 shsMarket Capitalization$499.87 millionP/E Ratio25.26Dividend YieldN/ABeta2 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2017, it owned and operated 228 dialysis clinics in partnership with 401 nephrologist partners treating approximately 15,600 patients in 26 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts. Receive ARA News and Ratings via Email Sign-up to receive the latest news and ratings for ARA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical SymbolNYSE:ARA CUSIPN/A Webwww.americanrenal.com Phone978-922-3080 Debt Debt-to-Equity Ratio4.63 Current Ratio1.15 Quick Ratio1.10 Price-To-Earnings Trailing P/E Ratio25.26 Forward P/E Ratio23.94 P/E Growth0.93 Sales & Book Value Annual Sales$745.11 million Price / Sales0.67 Cash Flow$1.9031 per share Price / Cash8.05 Book Value$3.83 per share Price / Book4.00 Profitability EPS (Most Recent Fiscal Year)$0.61 Net Income$4.85 million Net Margins0.60% Return on Equity16.88% Return on Assets2.26% Miscellaneous Employees4,692 Outstanding Shares32,440,000Market Cap$499.87 American Renal Associates (NYSE:ARA) Frequently Asked Questions What is American Renal Associates' stock symbol? American Renal Associates trades on the New York Stock Exchange (NYSE) under the ticker symbol "ARA." How were American Renal Associates' earnings last quarter? American Renal Associates Holdings Inc (NYSE:ARA) posted its quarterly earnings results on Tuesday, May, 8th. The company reported $0.11 EPS for the quarter, topping the Zacks' consensus estimate of $0.09 by $0.02. The firm had revenue of $194.67 million for the quarter, compared to analysts' expectations of $189.10 million. American Renal Associates had a net margin of 0.60% and a return on equity of 16.88%. The business's revenue for the quarter was up 10.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.07 earnings per share. View American Renal Associates' Earnings History. When is American Renal Associates' next earnings date? American Renal Associates is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for American Renal Associates. What price target have analysts set for ARA? 3 brokerages have issued 1-year price targets for American Renal Associates' stock. Their forecasts range from $20.00 to $22.00. On average, they expect American Renal Associates' share price to reach $21.00 in the next year. This suggests a possible upside of 37.1% from the stock's current price. View Analyst Ratings for American Renal Associates. What is the consensus analysts' recommendation for American Renal Associates? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for American Renal Associates in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of American Renal Associates' key competitors? Some companies that are related to American Renal Associates include Tivity Health (TVTY), Catasys (CATS), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHO), BioRestorative Therapies (BRTX), MYnd Analytics (MYND), Hooper Holmes (HPHW) and American Caresource (GNOW). Who are American Renal Associates' key executives? American Renal Associates' management team includes the folowing people: Mr. Joseph A. Carlucci, Co-Founder, CEO & Chairman (Age 64)Mr. Syed T. Kamal, Founder, Pres & Director (Age 65)Mr. Jonathan L. Wilcox, VP & CFO (Age 44)Dr. Don E. Williamson, Exec. VP & COO (Age 55)Mr. Jason M. Boucher, VP of Fin., Chief Accounting Officer & Treasurer (Age 46) When did American Renal Associates IPO? (ARA) raised $161 million in an initial public offering on Thursday, April 21st 2016. The company issued 7,500,000 shares at $20.00-$23.00 per share. BofA Merrill Lynch, Barclays and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Has American Renal Associates been receiving favorable news coverage? Media headlines about ARA stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. American Renal Associates earned a media sentiment score of 0.14 on Accern's scale. They also assigned news coverage about the company an impact score of 45.17 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future. How do I buy shares of American Renal Associates? Shares of ARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is American Renal Associates' stock price today? One share of ARA stock can currently be purchased for approximately $15.32. How big of a company is American Renal Associates? American Renal Associates has a market capitalization of $499.87 million and generates $745.11 million in revenue each year. The company earns $4.85 million in net income (profit) each year or $0.61 on an earnings per share basis. American Renal Associates employs 4,692 workers across the globe. How can I contact American Renal Associates? American Renal Associates' mailing address is 500 CUMMINGS CENTER SUITE 6550, BEVERLY MA, 01915. The company can be reached via phone at 978-922-3080 or via email at [email protected] MarketBeat Community Rating for American Renal Associates (NYSE ARA)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 117 (Vote Outperform)Underperform Votes: 123 (Vote Underperform)Total Votes: 240MarketBeat's community ratings are surveys of what our community members think about American Renal Associates and other stocks. Vote "Outperform" if you believe ARA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: What does EPS mean?